Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
41 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (YRDC) is a technology transfer company that specializes in marketing the inventions and know-how generated by the University's researchers and students. The company transfers the technologies in fields that include agriculture and nutrition, water and environmental technologies, nanotechnology, medicine and pharmaceuticals, computer science, and homeland security and others. It assists business partners in identifying the expert researcher to undertake the research and tailor the partnerships to the requirements of the business partner and the technologies. YRDC is headquartered in Givat Ram, Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that

  
Source:
Document ID
GDPH175650D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Medical Devices Deals, 2010 to YTD 201691
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016103
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Pharmaceuticals &Healthcare, Deal Details1324
  Venture Financing131
    Avraham Pharma Raises up to USD4 Million Financing132
    Avraham Pharma Raises USD4.5 Million in Venture Financing152
    Avraham Pharma Raises US$6 Million In Venture Financing172
    Integra Holdings Raises US$7 Million In First Round Financing191
    Avraham Pharma Secures US$3 Million In Venture Financing202
    Avraham Pharma Raises US$9 Million In Venture Financing222
  Licensing Agreements241
    Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company241
    BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem251
    Immune Pharma Enters into Licensing Agreement with Yissum262
    Immune Pharma to Enter into Licensing Agreement with Yissum Research Development282
    Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific301
    Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical311
    BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical322
    BioLineRx Enters Into Licensing Agreement With Yissum Research Development For BL-7040342
  Acquisition361
    Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra361
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Key Competitors371
Key Employees382
Locations And Subsidiaries401
  Head Office401
  Other Locations &Subsidiaries401
Appendix411
  Methodology411
  About GlobalData411
  Contact Us411
  Disclaimer411

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Yissum-Research-Development-Company-of-the-Hebrew-University-of-Jerusalem-Ltd-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10402>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Yissum-Research-Development-Company-of-the-Hebrew-University-of-Jerusalem-Ltd-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10402>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research